Freeline Therapeutics Holdings plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | -274.25 | -100% | -0.1109 | -100% |
| P/S |
|
30.93 | 56.99 | -45.72% |
|
|
| P/BV |
|
7.81 | 256.7 | -96.96% |
|
|
| P/FCF |
|
-0.2791 | -196.64 | -99.86% |
|
|
| Ev/Ebitda |
|
-3.78 | 12.51 | -130.26% |
|
|
| Ev/S |
|
591.32 | 468.02 | 26.34% |
|
|
| Ev/FCF |
|
-5.35 | -237.28 | -97.75% |
|
|
| E/P |
|
-2.6 | 0.0224 | -11725.65% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-15627.01 | -341.3 | 4478.7% | -15382.02 | +1.59% |
| ROE |
|
-102.94 | 103.63 | -199.33% |
|
|
| ROA |
|
-78.13 | -2.84 | 2652.78% |
|
|
| ROIC |
|
-57.83 | 1.17 | -5026.13% |
|
|
| ROS |
|
-8027.65 | -298.77 | 2586.92% |
|
|
| ROCE |
|
-187.79 | 3.3 | -5791.05% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0607 | 0.9675 | -106.27% | -0.0608 | -0.1083% |
| Nеt Debt/Ebitda |
|
0.4259 | 1.05 | -59.4% |
|
|
| Debt/Ratio |
|
0.0681 | 0.179 | -61.95% |
|
|
| Debt/Equity |
|
0.6527 | 1.58 | -58.82% |
|
|
| Debt/Net Income |
|
-0.1182 | -1.51 | -92.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5335 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.2238 | -100% |
|
|
| Average dividend growth |
|
0 | 0.6549 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5095 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.63 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5335 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
1/10
|
0.8104 | -90.69 | -100.89% | ||
| Growth impulse Ebitda in 5 years |
|
78.35 | -111.17 | -170.48% | ||
| Growth impulse Net Income in 5 years |
|
-7.53 | -103.34 | -92.71% | ||
| Growth impulse FCF in 5 years |
|
25.08 | -114.74 | -121.86% | ||
| Growth impulse EPS in 5 years |
|
-99.98 | -98.04 | 1.98% |
IP Score
3.03/10
